WHI-P180

Inquiry

Cat. No.: DIA-0230055

Size: 50 mg Size: 500 mg Size: Customer Size

Product Information
CAS No.	211555-08-7
Formula	C₁₆H₁₅N₃O₃
Molecular Weight	297.31
SMILES	COC1=CC2=NC=NC(=C2C=C1OC)NC3=CC(=CC=C3)O
Product Description	WHI-P180 is a multi-kinase inhibitor with IC50 values of 4.5 and 66 nM for the human proto-oncogene RET and kinase insert domain receptor (KDR) , respectively.

Format & Storage
Purity	> 98%
Shipping	Shipped on dry ice.
Storage	Powder: -20 °C, 3 years; 4 °C, 2 years In solvent: -80 °C, 6 months; -20 °C, 1 month
Solubility Overview	Soluble in DMSO

All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Ace Therapeutics has a team of wellknown experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links

Contact Info

Top